Cargando…

Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome

AIM: The purpose of this study was to treat burning mouth syndrome (BMS) with a combination of painful gabapentin and ultramicronized palmitoylethanolamide (umPEA), in an attempt to improve the severe symptomatology of BMS. METHODS: We examined the case of a 60-year-old male, suffering from late-ons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chirchiglia, Domenico, Chirchiglia, Pasquale, Marotta, Rosa, Gallelli, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385774/ https://www.ncbi.nlm.nih.gov/pubmed/30858732 http://dx.doi.org/10.2147/IMCRJ.S194403

Ejemplares similares

Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine With Aura: A Pilot Study
por: Chirchiglia, Domenico, et al.
Publicado: (2018)

De Chirico and Alice in Wonderland Syndrome: When Neurology Creates Art
por: Chirchiglia, Domenico, et al.
Publicado: (2018)

An unusual association of headache, epilepsy, and late-onset Kleist’s pseudodepression syndrome in frontal lobe cavernoma of the cerebral left hemisphere
por: Chirchiglia, Domenico, et al.
Publicado: (2017)

Administration of palmitoylethanolamide in combination with topiramate in the preventive treatment of nummular headache
por: Chirchiglia, Domenico, et al.
Publicado: (2016)

Postural instability after lumbar spinal surgery: are there any predictive factors? A case control study
por: Chirchiglia, Domenico, et al.
Publicado: (2018)

Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain
por: Cocito, Dario, et al.
Publicado: (2014)

Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation
por: Roncati, Luca, et al.
Publicado: (2021)

Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells
por: Barbierato, Massimo, et al.
Publicado: (2015)

Comment on “Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain”
por: Kriek, R.
Publicado: (2014)

Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: D’Amico, Ramona, et al.
Publicado: (2021)

The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms
por: Passavanti, Maria Beatrice, et al.
Publicado: (2017)

Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man
por: Caltagirone, Carlo, et al.
Publicado: (2015)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
por: Petrosino, Stefania, et al.
Publicado: (2018)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
por: Noce, Annalisa, et al.
Publicado: (2021)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury
por: Crupi, Rosalia, et al.
Publicado: (2016)

Combination of Rehabilitative Therapy with Ultramicronized Palmitoylethanolamide for Chronic Low Back Pain: An Observational Study
por: Scaturro, Dalila, et al.
Publicado: (2019)

A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
por: Paterniti, Irene, et al.
Publicado: (2013)

Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
por: Facchinetti, Roberta, et al.
Publicado: (2020)

Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABA(B)-ergic activity and cortical plasticity in long COVID-19 syndrome
por: Versace, Viviana, et al.
Publicado: (2023)

Erratum to: A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
por: Paterniti, Irene, et al.
Publicado: (2016)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
por: Stochino Loi, Emanuela, et al.
Publicado: (2019)

Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat
por: Peritore, Alessio Filippo, et al.
Publicado: (2020)

Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study
por: Albanese, Maria, et al.
Publicado: (2022)

The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice
por: Cristiano, Claudia, et al.
Publicado: (2022)

Oral Supplementation with Ultramicronized Palmitoylethanolamide for Joint Disease and Lameness Management in Four Jumping Horses: A Case Report
por: Gugliandolo, Enrico, et al.
Publicado: (2020)

Co-Ultramicronized Palmitoylethanolamide/Luteolin-Induced Oligodendrocyte Precursor Cell Differentiation is Associated With Tyro3 Receptor Upregulation
por: Facci, Laura, et al.
Publicado: (2021)

Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer’s Disease
por: Facchinetti, Roberta, et al.
Publicado: (2022)

Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain
por: Boccella, Serena, et al.
Publicado: (2019)

Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects
por: Scuderi, Caterina, et al.
Publicado: (2018)

Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Falcine meningioma in Von Hippel–Lindau disease: An unusual association
por: Murrone, Domenico, et al.
Publicado: (2018)

Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages
por: Del Re, Alessandro, et al.
Publicado: (2021)

Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain
por: Nie, Lingdi, et al.
Publicado: (2021)

A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis
por: Contarini, Gabriella, et al.
Publicado: (2019)

Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double‐blind, multicentre, randomized, placebo‐controlled study
por: Noli, Chiara, et al.
Publicado: (2019)

Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial
por: Di Stadio, Arianna, et al.
Publicado: (2022)

Burning Mouth Syndrome
por: Mock, David, et al.
Publicado: (2010)

Burning mouth syndrome
por: Jimson, Sudha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0ntr5mkmfc8nfmdj4almaskffq